Diversified Healthcare Trust (DHC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

In This Article:

  • Total Revenue: $379.6 million for Q4, a 5% year-over-year increase.

  • Normalized FFO: $5.3 million or $0.02 per share, exceeding consensus estimates.

  • Shop Occupancy: Reached 80% for the first time since Q1 2020.

  • Shop NOI Improvement: 56% year-over-year increase.

  • Shop Revenue Increase: 7.3% year-over-year increase.

  • Average Monthly Rate Increase: 6.7% year-over-year increase.

  • Shop Expense Increase: 3.9%, driven by salary, wages, and maintenance.

  • Medical Office and Life Science Leasing: 112,000 square feet of new and renewal leasing activity with rents 6.9% higher than prior.

  • Same Store Occupancy: Flat at 90.2%.

  • Proceeds from Property Sales: $6.6 million in Q4 and $179 million in Q1 2025.

  • Cash Dividend from Alaris: $17 million from a 34% ownership stake.

  • Unrestricted Cash: Approximately $145 million at quarter-end.

  • CapEx Spend: $73 million in Q4, $191 million for full year 2024.

  • 2025 CapEx Guidance: $150 million to $170 million.

  • 2025 NOI Guidance: $120 million to $135 million for shop segment, $104 million to $112 million for medical office and life science segment.

Release Date: February 26, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Diversified Healthcare Trust (NASDAQ:DHC) reported a 5% year-over-year increase in total revenues for the fourth quarter, reaching $379.6 million.

  • The company achieved 80% shop occupancy for the first time since the first quarter of 2020, indicating a positive trend in their shop sector performance.

  • DHC completed approximately 112,000 square feet of new and renewal leasing activity with weighted average rents 6.9% higher than prior rents for the same space.

  • The company successfully sold properties, including the Muse Life Science campus in San Diego for $159 million, contributing to their strategic disposition efforts.

  • DHC has made significant progress on its financing strategy, with three executed term sheets and one in final negotiation stages for $340 million in anticipated loan proceeds.

Negative Points

  • DHC experienced a sequential quarter decline in same property cash basis NOI by 1.4%, mainly due to additional insurance and remediation costs from hurricanes.

  • The company faces a significant upcoming debt maturity of $380 million due in June 2025, requiring careful financial management.

  • DHC's same store occupancy remained flat at 90.2%, indicating challenges in improving occupancy rates.

  • The company is dealing with known vacates, including a major tenant in St. Louis, Missouri, which could impact future revenue.

  • DHC's refinancing strategy is contingent on the completion of diligence and certain structuring requirements, which introduces uncertainty in the timing of loan closings.